down arrow

TTK Healthcare

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE910C01018
  • NSEID: TTKHLTCARE
  • BSEID: 507747
INR
1,200.00
36.75 (3.16%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.98 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Standalone Annual Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 3.82% vs 21.00% in Mar 2023

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2024 is -90.18% vs 1,438.13% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 19.04% vs 43.61% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is -47.33% vs 61.73% in Mar 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2024 has improved from Mar 2023

Compare Annual Results Of TTK Healthcare With
Markets Mojo
Figures in Rs cr
Standalone Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
752.79
8,558.51
-7,805.72
-91.20%
Other Operating Income
0.00
0.00
0.00
Total Operating income
752.79
8,558.51
-7,805.72
-91.20%
Raw Material Cost
173.26
859.11
-685.85
-79.83%
Purchase of Finished goods
175.59
1,825.86
-1,650.27
-90.38%
(Increase) / Decrease In Stocks
-10.60
-60.74
50.14
82.55%
Employee Cost
132.84
1,890.84
-1,758.00
-92.97%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
244.38
1,859.00
-1,614.62
-86.85%
Total Expenditure (Excl Depreciation)
715.47
6,374.07
-5,658.60
-88.78%
Operating Profit (PBDIT) excl Other Income
37.32
2,184.44
-2,147.12
-98.29%
Other Income
62.61
266.64
-204.03
-76.52%
Operating Profit (PBDIT)
99.93
2,451.08
-2,351.15
-95.92%
Interest
2.76
14.57
-11.81
-81.06%
Exceptional Items
0.00
103.53
-103.53
-100.00%
Gross Profit (PBDT)
97.17
2,436.51
-2,339.34
-96.01%
Depreciation
13.06
317.46
-304.40
-95.89%
Profit Before Tax
84.12
2,119.05
-2,034.93
-96.03%
Tax
21.28
399.17
-377.89
-94.67%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
62.84
1,719.88
-1,657.04
-96.35%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
103.53
-103.53
-100.00%
Net Profit
62.84
1,823.41
-1,760.57
-96.55%
Equity Capital
14.13
40.06
-25.93
-64.73%
Face Value
10.00
1.00
0.00
Reserves
982.37
9,583.75
-8,601.38
-89.75%
Earnings per share (EPS)
44.47
45.52
-1.05
-2.31%
Diluted Earnings per share
44.47
45.45
-0.98
-2.16%
Operating Profit Margin (Excl OI)
4.96%
25.52%
0.00
-20.56%
Gross Profit Margin
12.91%
28.47%
0.00
-15.56%
PAT Margin
8.35%
20.10%
0.00
-11.75%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 752.79 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 3.82% vs 21.00% in Mar 2023

Annual - Standalone Net Profit
Standalone Net Profit 62.84 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -90.18% vs 1,438.13% in Mar 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 37.32 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 19.04% vs 43.61% in Mar 2023

Annual - Interest
Interest 2.76 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -47.33% vs 61.73% in Mar 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.96%
in Mar 2024

Figures in Rs %
stock-summary

YoY Growth in year ended Mar 2024 has improved from Mar 2023